Determining IFI44 as a key lupus nephritis’s biomarker through bioinformatics and immunohistochemistry
IFI44 is identified as a promising biomarker for LN, offering potential to refine the assessment of disease progression and predict clinical outcomes. This facilitates the development of more personalized treatment strategies for LN patients.
Authors
- Deyou Zhang
- Hao Wu (ORCID: https://orcid.org/0009-0004-9322-187X)
- Xueyao Wang (ORCID: https://orcid.org/0009-0009-9386-0088)
- Jiahui Wang (ORCID: https://orcid.org/0009-0000-9529-0749)
- Shuxian Wang (ORCID: https://orcid.org/0000-0002-9786-1717)
- Jinyu Yu (ORCID: https://orcid.org/0009-0003-7584-0354)
- Yue Tan
Institutions
- Jilin University (CN)
- First Hospital of Jilin University (CN)
Publication Details
- Journal
- Renal Failure
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1080/0886022x.2025.2479575
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00